GENEVA, Sept. 9 -- OTSUKA PHARMACEUTICAL CO., LTD. (2-9, Kanda Tsukasa-machi, Chiyoda-ku, Tokyo1018535) filed a patent application (PCT/JP2025/007225) for "USE OF CENTANAFADINE IN TREATMENT OF ADHD SYMPTOMS" on Feb 28, 2025. With publication no. WO/2025/183181, the details related to the patent application was published on Sep 04, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WARD, Caroline (2440 Research Boulevard, Rockville, Maryland20850), OBERDHAN, Dorothee (2440 Research Boulevard, Rockville, Maryland20850)
Abstract:
Methods of using centanafadine in treating ADHD and reducing ADHD...